Catalyst Wire Dossier Catalyst Wire Dossier

Anti-MUC1 CAR T Cells

· The First Affiliated Hospital of Guangdong Pharmaceutical University
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Anti-MUC1 CAR T Cells, covering 2018-05-16 to 2018-05-16. Get the full timeline:

Most recent: Clinical Trial Update: Anti-MUC1 CAR T Cells and PD-1 Knockout Engineered T Cells for NSCLC [Phase 1, Phase 2]

See pricing